Organogenesis Holdings: ReNu And New LCD Offer A Rebound Scenario
…
4,860€
41,28%
Echtzeit-Aktienkurs Organogenesis Holdings
Bid:
Ask:
Nachrichten zur Organogenesis Holdings Aktie
Organogenesis Holdings, Inc. (ORGO) Q3 2024 Earnings Call Transcript
…
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
CANTON, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company…
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024
CANTON, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company…
Organogenesis Holdings, Inc. (ORGO) Q2 2024 Earnings Call Transcript
…
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company…
Organogenesis Holdings, Inc. (ORGO) Q1 2024 Earnings Call Transcript
…
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
CANTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ: ORGO) a leading regenerative medicine company…
Organogenesis Holdings, Inc. (ORGO) Q4 2023 Earnings Call Transcript
…
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company…